The Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study cohort profile is now published in the International Journal of Epidemiology!
Predo is one of the big projects we have going on now. In total, 4,785 pregnant women participated in this study, 
which includes a clinical trial and a longitudinal cohort study to identify and prevent the risk factors for preeclampsia and intrauterine growth restriction, and to study their transgenerational consequences. Predo combines biomarker data from repeated samples with genomic and epigenomic information and measures of medical, psychological, environmental and socio-demographic characteristics in pregnant women, their partners and their children.
Right now, we’re inviting the school-age children and their parents to participate in the next follow-up phase – for more info in Finnish, visit the Predo site.
/Sara Sammallahti